Inventor · disambiguated record
Asa Abeliovich
Also filed as: ABELIOVICH ASA
13 granted patents·23 pending applications·47 citations·filing 2004–2024
90Inventor score
Files withPREVAIL THERAPEUTICS INC22ABELIOVICH ASA7UNIV COLUMBIA4ALECTOR LLC1THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF1
Top patents by PatentIndex Score
36 records- 0195US11661585B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted May 30, 2023·5 cites·19 claims
- 0295US11060113B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·8 cites·15 claims
- 0395US10689625B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2019·Granted Jun 23, 2020·10 cites·17 claims
- 0493US11655460B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·3 cites·14 claims
- 0593US10837028B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2019·Granted Nov 17, 2020·9 cites·17 claims
- 0686US11802294B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted Oct 31, 2023·2 cites·44 claims
- 0784US11993790B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted May 28, 2024·1 cites·20 claims
- 0882US9290759B2Optimized miRNA constructsABELIOVICH ASA·Filed 2011·Granted Mar 22, 2016·6 cites·8 claims
- 0981US11903985B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Feb 20, 2024·1 cites·24 claims
- 1081US11807849B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted Nov 7, 2023·1 cites·41 claims
- 1181US2025011783A1Gene therapy for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1275US11999974B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jun 4, 2024·1 cites·13 claims
- 1372US2024123003A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1469US12049626B2Gene therapy for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jul 30, 2024·0 cites·18 claims
- 1561US11470827B2Transgenic mice expressing human TREM proteins and methods of use thereofALECTOR LLC·Filed 2018·Granted Oct 18, 2022·0 cites·10 claims
- 1658US2023304036A1Aav vectors encoding parkin and uses thereofPREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1757US2023405149A1Gene therapies for neurodegenerative diseasePREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1857US2024100132A1Modulation of aav-based gene expressionPREVAIL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1955US2009004112A1Methods for the treatment of neurodegenerative diseases using nmda receptor glycine site antagonistsUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 2053US2022211871A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2153US2020283800A1Gene therapies for neurodegenerative diseasesPREVAIL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2251US2023346979A1Gene therapies for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2351US2023310654A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2451US2022010001A1Gene therapies for neurodegenerative diseasePREVAIL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2549US2014323581A1Transcriptome wiring analysis in parkinson's disease and uses thereofUNIV COLUMBIA·Filed 2012·Application pending·0 cites
- 2646US2016184454A1Rab7l1 interacts with lrrk2 to modify intraneuronal protein sorting and parkinson's disease riskABELIOVICH ASA·Filed 2014·Application pending·0 cites
- 2746US2021261981A1Gene therapies for neurodegenerative diseasesPREVAIL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2845US2011189308A1Methods to treat neurodegenerative conditions or diseases by targeting components of a pten signaling pathwayABELIOVICH ASA·Filed 2009·Application pending·0 cites
- 2945US2015337030A1Methods to treat alzheimer's disease using apoe inhibitorsUNIV COLUMBIA·Filed 2013·Application pending·0 cites
- 3043US2006275744A1Modified human embryonic stem cells and methods of use to treat neuron-associated disordersUNIV COLUMBIA·Filed 2005·Application pending·0 cites
- 3140US2016250182A1Rab7l1 interacts with lrrk2 to modify intraneuronal protein sorting and parkinson's disease riskTHE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF·Filed 2016·Application pending·0 cites
- 3239US2004247586A1Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereofFiled 2004·Application pending·0 cites
- 3337US2006183104A1Cellular models of neuron-associated disorders and uses thereofABELIOVICH ASA·Filed 2005·Application pending·0 cites
- 3436US2006153807A1Vector-mediated gene regulation in midbrain dopamine neuronsABELIOVICH ASA·Filed 2005·Application pending·0 cites
- 3536US2006171935A1Protecting cell therapy for neurological disorders including Parkinson's diseaseABELIOVICH ASA·Filed 2005·Application pending·0 cites
- 3631US2014193341A1Human induced neuronal cellsABELIOVICH ASA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Asa Abeliovich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →